Camp4 Therapeutics Market Sentiment

Camp4 Therapeutics Corp

CAMPNASDAQ

$3.91

-0.09-2.25%

Last update: Oct 5, 10:03 AM

$4.09

0.092.25%

Market sentiment signals for Camp4 Therapeutics (CAMP): analyst consensus, short interest, options flow and insider activity.

Analyst Consensus— Overweight

Short Interest▲ 2.2% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Overweight

12 analysts

Options Flow (P/C)

—

Avg Consensus PT

$10

+161.9%

Highest Price Target

$23

+488.2%

JP Morgan

Lowest Price Target

+53.5%

Chardan Capital

Short Interest

2.2%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 29, 2026	Chardan Capital	Keay Nakae—	+53.5%	$7 → $6	Maintained	Buy
Aug 14, 2026	Piper Sandler	Edward Tenthoff—	+283.6%	$12 → $15	Maintained	Overweight
Jun 16, 2026	JP Morgan	Anupam Rama—	+130.2%	$5 → $9	Upgrade	Neutral→Overweight
Jun 10, 2026	Chardan Capital	Keay Nakae—	+66.2%	$7	Initiate	Buy
Apr 14, 2026	Rodman & Renshaw	Seema Sheoran—	+79.0%	$7	Initiate	Buy
Apr 2, 2026	Leerink Partners	Mani Foroohar—	+130.2%	$8 → $9	Maintained	Outperform
Oct 2, 2025	Cantor Fitzgerald	Steve Seedhouse—	+79.0%	$7	Initiate	Overweight
Sep 16, 2025	JP Morgan	Anupam Rama—	—	—	Downgrade	Overweight→Neutral
Sep 15, 2025	Piper Sandler	Edward Tenthoff—	+206.9%	$18 → $12	Maintained	Overweight
May 27, 2025	Wedbush	Yun Zhong—	+104.6%	$8	Initiate	Outperform
Nov 5, 2024	William Blair	Myles Minter—	—	—	Initiate	Outperform
Nov 5, 2024	Leerink Partners	Mani Foroohar—	+334.8%	$17	Initiate	Outperform
Nov 5, 2024	JP Morgan	Eric Joseph—	+488.2%	$23	Initiate	Overweight
Nov 5, 2024	Piper Sandler	Edward Tenthoff—	+360.4%	$18	Initiate	Overweight
Jan 11, 2024	Goldman Sachs	Jerry Revich—	-92.3%	$0 → $0	Maintained	Sell
Oct 9, 2023	Goldman Sachs	Jerry Revich—	-91.0%	$1 → $0	Maintained	Sell
Oct 6, 2023	Craig-Hallum	Anthony Stoss—	-87.2%	$1	Downgrade	Buy→Hold
Oct 6, 2023	Roth MKM	Scott Searle—	+27.9%	$6 → $5	Maintained	Buy